Journal of Affective Disorders
Volume 70, Issue 2 , Pages 165-173 , July 2002

A comparison of characteristics of depressed patients and efficacy of sertraline and amitriptyline between Japan and the West

  • Masahiko Ohishi, M.S.

      Affiliations

    • Biometrics, Pfizer Pharmaceuticals Inc., Mitsui Building, 2-1-1, Nishi-Shinjuku, Shinjuku-ku, Tokyo 163-0461, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-3-5381-2985; fax: +81-3-3340-8176
    • ,
  • Kunitoshi Kamijima, M.D.

      Affiliations

    • Department of Psychiatry, Showa University School of Medicine, Tokyo, Japan

Received 20 October 2000 ,Accepted 15 February 2001.

References 

  1. Aitchison KJ, Jordan BD, Sharma T. The relevance of ethnic influences on pharmacogenetics to the treatment of psychosis. Drug Metab. Drug Interact. 2000;16:15–38
  2. Binitie A. A factor-analytical study of depression across cultures (African and European). Br. J. Psychiatry. 1975;127:559–563
  3. Brown C, Schulberg HC, Sacco D, et al.  Effectiveness of treatments for major depression in primary medical care practice: a post hoc analysis of outcomes for African American and white patients. J. Affect. Disord. 1999;53:185–192
  4. Cleary P, Guy W. Factor analysis of the Hamilton depression scale. Drugs Exp. Clin. Res. 1977;1:115–120
  5. Farooq S, Gahir MS, Okyere E, et al.  Somatization: a transcultural study. J. Psychiatr. Res. 1995;39:883–888
  6. Flockhart DA. The role of cytochrome P450 2C19. Clin. Pharmacokinet. 1995;29(Suppl. 1):45–52
  7. Freeman, C.P., Milln, P., Freeman, H.L., 1988. A placebo-controlled, multiple-dose, double-blind comparative study of sertraline and amitriptyline in depressed out-patients. Unpublished.
  8. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry. 1960;23:56–62
  9. Hamilton M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967;6:278–296
  10. Jablensky A, Sartorius N, Gulbinat W, et al.  Characteristics of depressive patients contacting psychiatric services in four cultures. Acta Psychiatr. Scand. 1981;63:367–383
  11. Jann MW, Cohen LJ. The influence of ethnicity and antidepressant pharmacogenetics in the treatment of depression. Drug Metab. Drug Interact. 2000;16:39–67
  12. Kamijima K, Koyama T, Mita T, et al.  Clinical evaluation of sertraline hydrochloride, a selective serotonin reuptake inhibitor in the treatment of depression and depressive state: a double-blind, group comparison study of sertraline hydrochloride vs. amitriptyline hydrochloride. Japan J. Neuropsychopharmacol. 1997;19:529–548
  13. Kitanishi K. The transcultural study on depression: Japan and Switzerland. Seishin Igaku. 1981;23:331–339
  14. Mowbray RM. The Hamilton Rating Scale for depression: a factor analysis. Psychol. Med. 1972;2:272–280
  15. Murasaki M, Kamijima K, Yamashita I, et al.  Clinical evaluation of sertraline hydrochloride, a selective serotonin reuptake inhibitor for depression and depressive state: a double-blind study compared with imipramine hydrochloride. Japan J. Neuropsychopharmacol. 1997;19:505–527
  16. Nakane Y, Ohta Y, Radford M, et al.  Comparative study of affective disorders in three Asian countries. Acta Psychiatr. Scand. 1991;84:313–319
  17. Ohishi M, Miyaoka H, Kamijima K. Demographic and symptomatic characteristics of depressed patients in clinical studies in Japan, USA, and Europe. In: XXIst CINP Congress, Glasgow. 1998;
  18. Olesen OV, Linnet K. Hydroxylation and demethylation of the tricyclic antidepressant nortriptyline by cDNA expressed human cytochrome P-450 isozymes. Drug Metab. Dispos. 1997;25:740–744
  19. Perris C, Eisemann M, Eriksson U, et al.  Transcultural aspects of depressive symptomatology. Psychiatr. Clin. 1981;14:69–80
  20. Radford M, Nakane Y, Ohta Y, et al.  A study of depression in two cultures: a transcultural study with Japanese and Australian clinically depressed patients. Jpn. Psychiatry Neurol. 1989;43:119–132
  21. Reimherr FW, Chouinard G, Cohn CK, et al.  Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. J. Clin. Psychiatry. 1990;51(12, Suppl. B):18–27
  22. Richelson E. Pharmacology of antidepressants in use in the United States. J. Clin. Psychiatry. 1982;43:4–13
  23. Teja JS, Narang RL, Aggarwal AK. Depression across cultures. Br. J. Psychiatry. 1971;119:253–260
  24. Venkatakrishnan K, Greenblatt DJ, von Moltke LL, et al.  Five distinct human cytochromes mediate amitriptyline N-demethylation in vitro: dominance of CYP 2C19 and 3A4. J. Clin. Pharmacol. 1998;38:112–121

PII: S0165-0327(01)00340-8

Journal of Affective Disorders
Volume 70, Issue 2 , Pages 165-173 , July 2002

Article Tools

* Image Usage & Resolution